NGP asked Staf C. Van Cauter, EVP of Bioscan Inc., how functional molecular imaging helps researchers to distinguish between a drug that fails and a study that fails to test the drug properly.
Randox Laboratories is the leading manufacturer of diagnostic products in the UK and one of the fastest growing clinical diagnostic companies in the world, ranking 23rd in the world for clinical diagnostics.
The “Design of small molecule therapeutics for the treatment of Alzheimer’s Disease based on the discovery of Innovative drug Targets” (ADIT) is one of three large collaborative research projects in Alzheimer’s disease funded by the European Union's Framework Programme 6.
A Definition of Terms and the Implications for Drug Development Efforts.
By Dr. David Gauvin